Grant: Discovery Grants Program - Individual
University of Toronto
$99,000.00
Amphoteric Molecules: from Reaction Discovery to Applications in Synthesis
EF 2017-18
Résumé
Our research program aims at the development and synthetic application of amphoteric reagents. As part of our efforts, we will be pursuing the chemistry of molecules that contain counterintuitive combinations of nucleophilic and electrophilic reaction centers. The bifunctional nature arising from ""forced orthogonality"" enables amphoteric molecules to participate in reactions of high atom- and step- economy. The capacity of these molecules to engage in multicomponent, cascade, and tandem processes makes them ideal tools for reaction discovery, medicinal chemistry, and green technology. Over the next 5 years, we will create a sophisticated portfolio of amphoteric reactivity, seeking applications that will range from fundamentally significant chemical transformations to understanding the properties of target molecules under consideration. These investigations will enable a wide range of academic and industrial researchers to run novel multicomponent processes using a growing collection of amphoteric molecules, explore the reactivity of ""borointermediates"" (molecules equipped with well-known functional groups in which a selected carbon atom(s) has been replaced by boron), and develop medicinal chemistry applications using our discoveries. Our studies will have practical significance and will be of broad applicability to pharmaceutical manufacturing because we will commercialize and market all synthetically useful reagents resulting from our efforts. In order to do this, we will take full advantage of our existing relationship with Sigma Aldrich. Our ties with the pharmaceutical industry, exemplified by active research collaborations with Merck, Pfizer, AstraZeneca, and GlaxoSmithKline will serve as a powerful platform to translate our research findings to a diverse range of Canadian stakeholders.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
217572-2013
Name nom
Yudin, Andrei
Department département
Chemistry (St. George Campus)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2013
Award amount
99000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3704
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Synthetic methodology
Research subject fr
Méthodologie en synthèse
Partie
5
Nb partie
5
Application title
Amphoteric Molecules: from Reaction Discovery to Applications in Synthesis
Keyword
NSERC
Application summary
Our research program aims at the development and synthetic application of amphoteric reagents. As part of our efforts, we will be pursuing the chemistry of molecules that contain counterintuitive combinations of nucleophilic and electrophilic reaction centers. The bifunctional nature arising from ""forced orthogonality"" enables amphoteric molecules to participate in reactions of high atom- and step- economy. The capacity of these molecules to engage in multicomponent, cascade, and tandem processes makes them ideal tools for reaction discovery, medicinal chemistry, and green technology. Over the next 5 years, we will create a sophisticated portfolio of amphoteric reactivity, seeking applications that will range from fundamentally significant chemical transformations to understanding the properties of target molecules under consideration. These investigations will enable a wide range of academic and industrial researchers to run novel multicomponent processes using a growing collection of amphoteric molecules, explore the reactivity of ""borointermediates"" (molecules equipped with well-known functional groups in which a selected carbon atom(s) has been replaced by boron), and develop medicinal chemistry applications using our discoveries. Our studies will have practical significance and will be of broad applicability to pharmaceutical manufacturing because we will commercialize and market all synthetically useful reagents resulting from our efforts. In order to do this, we will take full advantage of our existing relationship with Sigma Aldrich. Our ties with the pharmaceutical industry, exemplified by active research collaborations with Merck, Pfizer, AstraZeneca, and GlaxoSmithKline will serve as a powerful platform to translate our research findings to a diverse range of Canadian stakeholders.